These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19582339)

  • 1. Analysis of histopathological aspects in acquired middle ear cholesteatoma.
    Alves AL; Pereira CSB; Ribeiro FAQ; Fregnani JHTG
    Braz J Otorhinolaryngol; 2008; 74(6):835-841. PubMed ID: 19582339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR expression in acquired middle ear cholesteatoma in children and adults.
    Alves AL; Pereira CS; Carvalho Mde F; Fregnani JH; Ribeiro FQ
    Eur J Pediatr; 2012 Feb; 171(2):307-10. PubMed ID: 21800041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
    Ayache S; Tramier B; Strunski V
    Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
    Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
    Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological considerations about middle ear cholesteatoma.
    Măru N; Pop F
    Rom J Morphol Embryol; 2006; 47(1):73-7. PubMed ID: 16838062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of acquired cholesteatoma between pediatric and adult patients.
    Dornelles Cde C; da Costa SS; Meurer L; Rosito LP; da Silva AR; Alves SL
    Eur Arch Otorhinolaryngol; 2009 Oct; 266(10):1553-61. PubMed ID: 19322578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advance research on the pathogenesis of middle ear cholesteatoma].
    Li Q; Jiang H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 30(4):338-41. PubMed ID: 27373050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of acquired cholesteatoma of the human middle ear: support for the migration hypothesis.
    Karmody CS; Northrop C
    Otol Neurotol; 2012 Jan; 33(1):42-7. PubMed ID: 22143292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital cholesteatomas in the tympanic membrane.
    Weber PC; Adkins WY
    Laryngoscope; 1997 Sep; 107(9):1181-4. PubMed ID: 9292600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
    Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
    Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
    Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
    Welkoborsky HJ; Jacob RS; Hinni ML
    Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alterations of the basal membrane in middle ear cholesteatoma].
    Bernal Sprekelsen M; Ebmeyer J; Anonopoulos A; Borkowski G; Sudhoff H
    Acta Otorrinolaringol Esp; 2001 May; 52(4):330-5. PubMed ID: 11526629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
    Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study.
    Lei Y; An J; Ren Q; Wang M; Gao M
    Medicine (Baltimore); 2023 Oct; 102(43):e35538. PubMed ID: 37904429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the gap junction proteins connexin 26 and connexin 43 in human middle ear cholesteatoma.
    Choung YH; Park K; Kang SO; Markov Raynov A; Ho Kim C; Choung PH
    Acta Otolaryngol; 2006 Feb; 126(2):138-43. PubMed ID: 16428189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-R2 expression in acquired middle ear cholesteatoma.
    Vitale RF; Pereira CSB; Alves AL; Fregnani JHTG; Ribeiro FQ
    Braz J Otorhinolaryngol; 2011; 77(4):531-536. PubMed ID: 21860983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Condition of the anterior part of the middle ear cleft in acquired cholesteatoma.
    Albera R; Nadalin J; Garzaro M; Lacilla M; Pecorari G; Canale A
    Acta Otolaryngol; 2008 Jun; 128(6):634-8. PubMed ID: 18568496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.